Jonathon Davidson is thrilled to be back at work
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Good afternoon and welcome back to the first HotCopper Highlights of 2025, I’m Jonathon Davidson. In this segment we look at companies on the community’s radar – let’s get into it.

The week kicked off with Bellevue Gold as the stock sunk 13% after a downgrade to fiscal year revenue projections. Also of concern, the company removed projections for the cost of mining its gold in the latest update. 

Elsewhere, counter UAV tech stock Droneshield fielded views and generated talk after a $10M contract in Latin America. The stock was a darling last year but its lofty market cap crashed to reality when short sellers moved in. 

At any rate, the company’s one year returns remain just under 100%. 

Finally, current market darling Mesoblast caused both concern and calm when it halted trades on Friday ahead of news about ‘proposed financing.’ The stock is up 800% year on year, the question now is: can the stock keep running?

That was the most viewed stocks – and as for the most discussed. 

Recurring character Brainchip was at the top of the boards alongside Mesoblast as the former continues pressing ahead with its brain-based microchip tech. Brainchip has long repeatedly promised big things, and the latest AI craze has hit its shores.

Meanwhile, Star Entertainment revealed it might go bankrupt – it’s been death of a thousand cuts for that company in recent years. Zip Co and Imugene, forever HotCopper favourites, also remained busy on the forums.

That’s it for this week’s HotCopper Highlights, I’m Jonathon Davidson, have a great weekend and we’ll see you on Monday. 

More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…